An Insurance Company Doing the Right Thing (with Calprotectin)

“An Insurance Company Doing the Right Thing” –not The Onion headline this time.

Recently (April 7. 2019) United Healthcare put out a policy statement explicitly stating:

“Fecal measurement of calprotectin is proven and medically necessary for establishing the diagnosis or for management of the following:

  • Crohn’s Disease
  • Ulcerative Colitis”

Thanks to Kim Conn for identifying this policy.

The policy statement provides an in-depth rationale for why calprotectin is medically-indicated along with supporting recommendations from multiple GI societies and National Institute for Health and Care Excellence (NICE).  The policy statement includes a long list of references and would provide a strong argument in supporting calprotectin testing for all insurance providers.

Here’s the link: FECAL CALPROTECTIN TESTING United Healthcare.

Related blog posts:

Lots of lazy river floating. Deschutes River, Bend OR

6 thoughts on “An Insurance Company Doing the Right Thing (with Calprotectin)

  1. Pingback: What is the Calprotectin Threshold for Disease Progression in Crohn’s Disease? | gutsandgrowth

  2. Pingback: Narrowing the Workup for Chronic Abdominal Pain –Carlo DiLorenzo Was Right! | gutsandgrowth

  3. Pingback: New and Improved Biomarker Blood Test for Crohn’s Disease? | gutsandgrowth

  4. Pingback: IBD Update (November 2020) | gutsandgrowth

  5. Pingback: Normative Data for Fecal Calprotectin, age 4-16 yrs | gutsandgrowth

  6. Pingback: Calprotectin Less Accurate for Isolated Ileal Crohn’s Disease | gutsandgrowth

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.